MS Trust Information

Homeopathic products

Thu, 29 Jul 2010 00:00:00 +0100

The Department of Health has just published its response to the report of the House of Commons Science and Technology Committee Evidence Check 2: Homeopathy.

Measuring the NHS against user expectations

Tue, 20 Jul 2010 00:00:00 +0100

The government is launching a consultation on a raft of measures that will check NHS performance against outcomes and how users feel about services.

Review of social care funding launched

Tue, 20 Jul 2010 00:00:00 +0100

The government has taken the first steps to explore the future of funding for social care services.

What do the changes to the NHS mean for people with MS?

Tue, 13 Jul 2010 00:00:00 +0100

On 12 July the coalition government launched its white paper Equity and excellence: Liberating the NHS to change the NHS in England.

Cautious welcome for personal health budgets

Thu, 1 Jul 2010 00:00:00 +0100

The MS Trust cautiously welcomes the personal health budget scheme announced earlier this week.

Proposed benefit changes cause alarm

Thu, 1 Jul 2010 00:00:00 +0100

Proposed changes to the welfare system have caused alarm for some people with MS.

New website puts stem cells in the spotlight

Fri, 25 Jun 2010 00:00:00 +0100

While stem cells offer the potential for advances in the treatment of MS, much more research needs to be done to test their safety and effectiveness.

Pressure to save MS Society respite centres grows

Thu, 24 Jun 2010 00:00:00 +0100

On the 11 June the MS Society announced it is to stop providing specialist MS respite care at the four dedicated centres in the UK.

How will the budget affect you?

Wed, 23 Jun 2010 00:00:00 +0100

The Chancellor of the Exchequer, George Osborne, called yesterday's budget unavoidable as he announced plans to cut the structural budget deficit to zero in the next six years. Below are some of the key points that may impact on people with MS.

Update: cannabis-based drug approved for MS spasticity

Tue, 22 Jun 2010 00:00:00 +0100

The cannabis-based mouth spray, Sativex, has received approval from the UK drug's regulator (MHRA) as an add-on treatment for MS related spasticity.

BMJ fails to reflect all Risk-sharing Scheme comments in printed version

Wed, 16 Jun 2010 00:00:00 +0100

The printed version of the BMJ (published 12 June) carries last week's web based articles on the Risk-sharing Scheme but unfortunately fails to include the comments from the Chair of the Scientific Advisory group.

Government plans for the NHS

Wed, 9 Jun 2010 00:00:00 +0100

The coalition government has published Our Programme for Government giving greater detail on their policies.

Celebrating National Family Week

Mon, 31 May 2010 00:00:00 +0100

It's National Family Week this week and we are all being encouraged to celebrate family life and spend more quality time together.

Vitamin D: hope on the horizon for MS prevention?

Thu, 27 May 2010 00:00:00 +0100

An editorial in the latest issue of Lancet Neurology discusses the potential for vitamin D supplements to reduce the risk of developing multiple sclerosis.

World MS Day focuses on employment

Wed, 26 May 2010 00:00:00 +0100

The focus of this year's World MS day has been employment and multiple sclerosis.

Guidelines on male continence problems published by NICE

Thu, 20 May 2010 00:00:00 +0100

The MS Trust welcomes the new guidelines which address symptoms commonly experienced by men with multiple sclerosis.

Survey of sexual issues for men with MS

Wed, 19 May 2010 00:00:00 +0100

The MS Trust is asking men with multiple sclerosis for help in planning a new resource on the impact of the condition on sexuality.

Health care priorities for the next decade

Tue, 11 May 2010 00:00:00 +0100

Following the general election, the new team at the Department of Health, led by Health Secretary Andrew Lansley, will face a range of challenges.

Study of bone marrow stem cells in MS shows promise

Thu, 6 May 2010 00:00:00 +0100

One of the first stem cell trials in people with MS in the UK has shown possible benefits for the treatment of the condition.